Healthcare
Wellcome Trust invests £20m in Kymab
UK venture investor Wellcome Trust has injected £20m series-A funding into newly launched biopharmaceutical company Kymab.
FSI et al. invest €40m in Cerenis Therapeutics
The Fund for Strategic Investment (FSI) and existing investors have provided French biopharma Cerenis Therapeutics with a €40m series-C round of funding.
Riverside acquires Celvitae to boost Crioestaminal
The Riverside Company has acquired Spanish private cord blood bank Celvitae Biomédica S.A. which will join its portfolio company Crioestaminal.
Longbow leads £1.7m Ambicare funding
Longbow Capital has led a £1.7m funding round in medical devices firm Ambicare Health.
Oséo backs Cerenis and Novasep with €10.7m
The French government's venture arm Oséo has invested €10.7m in healthcare companies Cerenis Therapeutics and Groupe Novasep.
NBGI Private Equity acquires Praticdose
NBGI Private Equity has backed the management buy-in of French medical equipment provider Praticdose.
High-Tech Gründerfonds et al. invest €400,000 in Chromotek
High-Tech Gründerfonds and Bayern Kapital have provided biotechnology company Chromotek with €400,000.
Catapult exits R5 Pharmaceuticals
Catapult has exited its stake in R5 Pharmaceuticals, marking its second divestment this year.
Edmond de Rothschild et al. invest €16m in Poxel
Edmond de Rothschild Investment Partners (EdRIP), CDC Entreprises and Crédit Agricole Private Equity have provided biopharma Poxel with a €16m series-A round of financing.
Crédit Agricole PE et al. invest €7.5m in EyeTechCare
Crédit Agricole PE and insurance company SHAM have provided medical devices developer EyeTechCare with a €7.5m round of funding.
STING invests SEK 2m in ENCare
STING has injected SEK 2m in Swedish MedTech company ENCare.
EQT sells Aleris to Investor AB
EQT Partners has agreed to sell Aleris Holding AB to Investor AB for an enterprise value of SEK 4.4bn.
Waterland ups stake in Arseus
Waterland Private Equity has increased its stake in medical supplies and services company Arseus.
Life sciences: testing times ahead?
Pharmaceuticals and biotechnology have fared marginally better than other sectors during the global recession, but the last two years have still been lacklustre for private equity investments in life sciences. However, with a healthy number of deals already...
Vækstfonden provides funding for EntomoPharm
Vækstfonden has taken a stake in EntomoPharm for an undisclosed amount.
SV Life Sciences closes fifth fund on $523m
SV Life Sciences Fund V has closed on $523m, exceeding its $400m target.
Mercapital offers €135m for Teknon
Mercapital has made a €135m bid for Barcelona-based Centro Médico Teknon.
BC Partners lines up IPO for Fitness First
BC Partners is preparing to exit Fitness First in an IPO worth up to £1.2bn, according to reports.
Albion backs Masters Pharmaceuticals
Albion Ventures has invested £2.65m expansion capital in UK pharmaceutical supplier, Masters Pharmaceuticals.
Ashridge and Core commit £17.5m to Ark
Ashridge Capital and Core Capital have committed £17.5m to UK domiciliary healthcare provider, Ark Home Healthcare.
LBO France plans Medi-Partenaires exit
LBO France is working on plans to exit its stake in French healthcare provider, Medi-Partenaires SA, according to media reports.
Apax Patners sells remaining stake in Galapagos
Apax Partners' funds and listed vehicle Altamir Amboise has sold its 5.4% remaining stake in listed biotechnology company Galapagos.
IK Investment Partners acquire majority stake in Colosseum Dental
IK Investment Partners have acquired a majority stake in Norwegian dental care specialist Colosseum Dental.
NBF selects six managers for new £185m fund
Northwest Business Finance (NBF) has selected six UK private equity investors to manage its £184.8m North West Fund, set up to provide funding to small and medium-sized enterprises in the region.